- Home
- ICUCW vs VCEL Comparison
ICUCW vs VCEL Comparison
Compare ICUCW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICUCW
- VCEL
- Stock Information
- Founded
- ICUCW N/A
- VCEL 1989
- Country
- ICUCW United States
- VCEL United States
- Employees
- ICUCW 19
- VCEL N/A
- Industry
- ICUCW Biotechnology: Pharmaceutical Preparations
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ICUCW Health Care
- VCEL Health Care
- Exchange
- ICUCW Nasdaq
- VCEL Nasdaq
- Market Cap
- ICUCW N/A
- VCEL 2.1B
- IPO Year
- ICUCW 2021
- VCEL 1997
- Fundamental
- Price
- ICUCW $0.02
- VCEL $40.15
- Analyst Decision
- ICUCW
- VCEL Strong Buy
- Analyst Count
- ICUCW 0
- VCEL 8
- Target Price
- ICUCW N/A
- VCEL $62.00
- AVG Volume (30 Days)
- ICUCW N/A
- VCEL 423.4K
- Earning Date
- ICUCW N/A
- VCEL 07-31-2025
- Dividend Yield
- ICUCW N/A
- VCEL N/A
- EPS Growth
- ICUCW N/A
- VCEL 521.85
- EPS
- ICUCW N/A
- VCEL 0.05
- Revenue
- ICUCW N/A
- VCEL $238,541,000.00
- Revenue This Year
- ICUCW N/A
- VCEL $23.03
- Revenue Next Year
- ICUCW N/A
- VCEL $24.52
- P/E Ratio
- ICUCW N/A
- VCEL $803.09
- Revenue Growth
- ICUCW N/A
- VCEL 14.80
- 52 Week Low
- ICUCW N/A
- VCEL $37.39
- 52 Week High
- ICUCW N/A
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- ICUCW N/A
- VCEL 44.33
- Support Level
- ICUCW N/A
- VCEL $40.53
- Resistance Level
- ICUCW N/A
- VCEL $43.57
- Average True Range (ATR)
- ICUCW 0.00
- VCEL 1.62
- MACD
- ICUCW 0.00
- VCEL -0.16
- Stochastic Oscillator
- ICUCW 0.00
- VCEL 28.65
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.